Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-088815

Chief Financial Officer sold 10,780 shares at an average $8.56 ($92,316)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-29 Sale : show line 1 in the form 10b5-1 −1,702 $8.85 $15,063 328,728 D
2024-07-29 Sale : show line 2 in the form 10b5-1 −9,078 $8.51 $77,254 319,650 D
Open-market sales · 10,780 sh · avg $8.56 · $92,316
Loading xslF345X05/ownership.xml…